Snapshot
Extracorporeal Membrane Oxygenation (ECMO) Systems is a new treatment method aimed at heart and lung failure disease. ECMO transport is an effective method of transferring patients with severe ARDS. It has multiple causes, and the diagnosis should be investigated and treatment commenced during ECMO. Since ECMO is a complicated and high-risk therapy, adequate training in its performance and creation of a referring hospital network are essential.
The global Extracorporeal Membrane Oxygenation (ECMO) market will reach xxx Million USD in 2017 and CAGR xx% 2011-2017. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Extracorporeal Membrane Oxygenation (ECMO) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
VV ECMO
VA ECMO
Company Coverage (Sales Revenue, Price, Gross Margin, Main Products etc.):
Medtronic
Maquet
Sorin
Terumo
Xenios
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Neonatal
Pediatric
Adult
Region Coverage (Regional Output, Demand & Forecast by Countries etc.):
North America
Europe
Asia-Pacific
South America
Middle East & Africa